• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过高密度脂蛋白胆固醇评估白塞病风险:韩国全国基于人群的研究。

Risk for Behçet's disease gauged via high-density lipoprotein cholesterol: a nationwide population-based study in Korea.

机构信息

Department of Dermatology, College of Medicine, Seoul St. Mary's Hospital, The Catholic University of Korea, 222, Banpo-daero, Seocho-gu, Seoul, 06591, Republic of Korea.

Department of Dermatology, College of Medicine, Eunpyeong St. Mary's Hospital, The Catholic University of Korea, Seoul, Republic of Korea.

出版信息

Sci Rep. 2022 Jul 26;12(1):12735. doi: 10.1038/s41598-022-17096-0.

DOI:10.1038/s41598-022-17096-0
PMID:35882901
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9325767/
Abstract

Behçet's disease (BD) is a chronic inflammatory disease. Low levels of plasma high-density lipoprotein cholesterol (HDL-C) are associated with Crohn's disease, another chronic inflammatory disease. However, the effects of low HDL-C levels on BD are unclear. We investigated the effects of HDL-C levels, and variability therein, on the risk for BD. We used the Korean National Health Insurance System database to identify 5,587,754 adults without a history of BD who underwent ≥ 3 medical examinations between 2010 and 2013. Mean HDL-C levels at each visit were used to calculate variability independent of the mean (VIM) and the coefficient of variation (CV). There were 676 new cases of BD (0.012%). The risk for BD was increased in participants with highly variable and low mean HDL-C levels. In a multivariate-adjusted model, the hazard ratios (95% confidence intervals) for BD incidence were 1.335 (1.058-1.684) in a high mean/high VIM group, 1.527 (1.211-1.925) in a low mean/low VIM group, and 2.096 (1.67-2.63) in a low mean/high VIM group compared to a high mean/low VIM group. Low mean HDL-C levels, and high variability therein, are independent risk factors for BD.

摘要

贝赫切特病(BD)是一种慢性炎症性疾病。 血浆高密度脂蛋白胆固醇(HDL-C)水平低与另一种慢性炎症性疾病克罗恩病有关。 然而,低 HDL-C 水平对 BD 的影响尚不清楚。 我们研究了 HDL-C 水平及其变异性对 BD 风险的影响。 我们使用韩国国家健康保险系统数据库,确定了 5587754 名没有 BD 病史的成年人,这些成年人在 2010 年至 2013 年间接受了≥3 次体检。每次就诊的平均 HDL-C 水平用于计算独立于平均值的变异性(VIM)和变异系数(CV)。 有 676 例新 BD 病例(0.012%)。 在具有高度可变和低平均 HDL-C 水平的参与者中,BD 的风险增加。 在多变量调整模型中,BD 发病率的危险比(95%置信区间)在高平均/高 VIM 组为 1.335(1.058-1.684),在低平均/低 VIM 组为 1.527(1.211-1.925),在低平均/高 VIM 组为 2.096(1.67-2.63)与高平均/低 VIM 组相比。 低平均 HDL-C 水平及其高度变异性是 BD 的独立危险因素。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a8c1/9325767/194edc89a804/41598_2022_17096_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a8c1/9325767/59203b50f1c4/41598_2022_17096_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a8c1/9325767/4a0e0f53c3ee/41598_2022_17096_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a8c1/9325767/194edc89a804/41598_2022_17096_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a8c1/9325767/59203b50f1c4/41598_2022_17096_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a8c1/9325767/4a0e0f53c3ee/41598_2022_17096_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a8c1/9325767/194edc89a804/41598_2022_17096_Fig3_HTML.jpg

相似文献

1
Risk for Behçet's disease gauged via high-density lipoprotein cholesterol: a nationwide population-based study in Korea.通过高密度脂蛋白胆固醇评估白塞病风险:韩国全国基于人群的研究。
Sci Rep. 2022 Jul 26;12(1):12735. doi: 10.1038/s41598-022-17096-0.
2
HDL-Cholesterol, Its Variability, and the Risk of Diabetes: A Nationwide Population-Based Study.高密度脂蛋白胆固醇、其变异性与糖尿病风险:一项全国范围内基于人群的研究。
J Clin Endocrinol Metab. 2019 Nov 1;104(11):5633-5641. doi: 10.1210/jc.2019-01080.
3
Association between metabolic syndrome and Behçet's disease: A nationwide population-based study.代谢综合征与贝赫切特病的相关性:一项全国范围内基于人群的研究。
J Dermatol. 2021 Jul;48(7):1062-1066. doi: 10.1111/1346-8138.15809. Epub 2021 May 7.
4
Association of High-Density Lipoprotein Cholesterol Variability and the Risk of Developing Parkinson Disease.高密度脂蛋白胆固醇变异性与帕金森病发病风险的关联。
Neurology. 2021 Mar 9;96(10):e1391-e1401. doi: 10.1212/WNL.0000000000011553. Epub 2021 Feb 3.
5
Intra-individual variability in high density lipoprotein cholesterol and risk of end-stage renal disease: A nationwide population-based study.个体内高密度脂蛋白胆固醇变异性与终末期肾病风险:一项全国范围内基于人群的研究。
Atherosclerosis. 2019 Jul;286:135-141. doi: 10.1016/j.atherosclerosis.2019.05.018. Epub 2019 May 24.
6
Atherogenic lipid profile in Behçet's disease: evidence of alteration of HDL subclasses.贝切特病的致动脉粥样硬化脂质谱:高密度脂蛋白亚类改变的证据。
Arch Med Res. 2011 Apr;42(3):211-8. doi: 10.1016/j.arcmed.2011.05.001.
7
Visit-to-visit variability of lipid measurements and the risk of myocardial infarction and all-cause mortality: A prospective cohort study.随访间血脂变异性与心肌梗死及全因死亡率的关系:一项前瞻性队列研究。
Atherosclerosis. 2020 Nov;312:110-116. doi: 10.1016/j.atherosclerosis.2020.09.003. Epub 2020 Sep 9.
8
Impact of Mean and Variability of High-Density Lipoprotein-Cholesterol on the Risk of Myocardial Infarction, Stroke, and Mortality in the General Population.高密度脂蛋白胆固醇的均值和变异性对普通人群心肌梗死、卒中和死亡率风险的影响。
J Am Heart Assoc. 2020 Apr 7;9(7):e015493. doi: 10.1161/JAHA.119.015493. Epub 2020 Apr 6.
9
Incidence and clinical outcomes of intestinal Behçet's disease in Korea, 2011-2014: a nationwide population-based study.2011-2014 年韩国肠型贝赫切特病的发病和临床结局:一项全国基于人群的研究。
J Gastroenterol. 2017 Aug;52(8):920-928. doi: 10.1007/s00535-016-1300-3. Epub 2016 Dec 27.
10
Risk for Parkinson's Disease in Patients with Behçet's Disease: A Nationwide Population-Based Dynamic Cohort Study in Korea.韩国全国基于人群的动态队列研究:贝赫切特病患者患帕金森病的风险。
J Parkinsons Dis. 2019;9(3):583-589. doi: 10.3233/JPD-191622.

引用本文的文献

1
Lower total cholesterol and HDL-C levels are associated with increased risk of Behçet's disease in a prospective nationwide Korean study.在一项韩国全国性前瞻性研究中,总胆固醇和高密度脂蛋白胆固醇水平较低与白塞病风险增加相关。
Sci Rep. 2025 May 1;15(1):15272. doi: 10.1038/s41598-025-99179-2.
2
Mendelian randomization reveals probucol's preventive role in Behçet's disease via circulating metabolites.孟德尔随机化研究通过循环代谢物揭示了普罗布考在白塞病中的预防作用。
Sci Rep. 2025 Mar 21;15(1):9722. doi: 10.1038/s41598-025-93644-8.
3
The influence of uterine leiomyomatosis on the onset of psoriasis: a nationwide population-based study of 2.5 million Korean females.

本文引用的文献

1
Evaluation of atherogenic laboratory markers in Behçet's disease patients with vascular involvement.白塞病血管受累患者动脉粥样硬化实验室标志物的评估。
Arch Med Sci. 2019 Oct 27;16(3):531-537. doi: 10.5114/aoms.2018.79139. eCollection 2020.
2
Impact of Mean and Variability of High-Density Lipoprotein-Cholesterol on the Risk of Myocardial Infarction, Stroke, and Mortality in the General Population.高密度脂蛋白胆固醇的均值和变异性对普通人群心肌梗死、卒中和死亡率风险的影响。
J Am Heart Assoc. 2020 Apr 7;9(7):e015493. doi: 10.1161/JAHA.119.015493. Epub 2020 Apr 6.
3
Crohn's disease and ulcerative colitis are associated with different lipid profile disorders: a nationwide population-based study.
子宫平滑肌瘤病对银屑病发病的影响:一项基于韩国250万女性人群的全国性研究。
BMC Womens Health. 2025 Feb 5;25(1):50. doi: 10.1186/s12905-024-03529-7.
克罗恩病和溃疡性结肠炎与不同的脂质谱紊乱相关:一项全国范围内基于人群的研究。
Aliment Pharmacol Ther. 2020 Feb;51(4):446-456. doi: 10.1111/apt.15562. Epub 2019 Nov 6.
4
HDL-Cholesterol, Its Variability, and the Risk of Diabetes: A Nationwide Population-Based Study.高密度脂蛋白胆固醇、其变异性与糖尿病风险:一项全国范围内基于人群的研究。
J Clin Endocrinol Metab. 2019 Nov 1;104(11):5633-5641. doi: 10.1210/jc.2019-01080.
5
Intra-individual variability in high density lipoprotein cholesterol and risk of end-stage renal disease: A nationwide population-based study.个体内高密度脂蛋白胆固醇变异性与终末期肾病风险:一项全国范围内基于人群的研究。
Atherosclerosis. 2019 Jul;286:135-141. doi: 10.1016/j.atherosclerosis.2019.05.018. Epub 2019 May 24.
6
Biomarker variability and cardiovascular disease residual risk.生物标志物的变异性与心血管疾病残余风险。
Curr Opin Cardiol. 2019 Jul;34(4):413-417. doi: 10.1097/HCO.0000000000000627.
7
Immunopathogenesis of Behcet's Disease.贝赫切特病的免疫发病机制。
Front Immunol. 2019 Mar 29;10:665. doi: 10.3389/fimmu.2019.00665. eCollection 2019.
8
Effect of visit-to-visit LDL-, HDL-, and non-HDL-cholesterol variability on mortality and cardiovascular outcomes after percutaneous coronary intervention.经皮冠状动脉介入治疗后随访 LDL、HDL 和非 HDL-胆固醇变异性对死亡率和心血管结局的影响。
Atherosclerosis. 2018 Dec;279:1-9. doi: 10.1016/j.atherosclerosis.2018.10.012. Epub 2018 Oct 17.
9
Anti-Inflammatory Effects of HDL in Mice With Rheumatoid Arthritis Induced by Collagen.胶原诱导关节炎小鼠模型中 HDL 的抗炎作用。
Front Immunol. 2018 May 11;9:1013. doi: 10.3389/fimmu.2018.01013. eCollection 2018.
10
Past and Current Status of Adult Type 2 Diabetes Mellitus Management in Korea: A National Health Insurance Service Database Analysis.韩国成人2型糖尿病管理的过去与现状:一项国民健康保险服务数据库分析
Diabetes Metab J. 2018 Apr;42(2):93-100. doi: 10.4093/dmj.2018.42.2.93.